Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H8 |
| Molecular Weight | 92.1384 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=CC=C1
InChI
InChIKey=YXFVVABEGXRONW-UHFFFAOYSA-N
InChI=1S/C7H8/c1-7-5-3-2-4-6-7/h2-6H,1H3
| Molecular Formula | C7H8 |
| Molecular Weight | 92.1384 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Toluene is a colorless, water-insoluble liquid with the smell associated with paint thinners. It is a mono-substituted benzene derivative, consisting of a CH3 group attached to a phenyl group. The major use of toluene is as a mixture added to gasoline to improve octane ratings. Toluene is also usedto produce benzene and as a solvent in paints, coatings, synthetic fragrances, adhesives, inks, and cleaningagents. Toluene is also used in the production of polymers used to make nylon, plastic soda bottles, andpolyurethanes and for pharmaceuticals, dyes, cosmetic nail products, and the synthesis of organicchemicals. The CNS is the primary target organ for toluene toxicity in both humans and animals for acute and chronicexposures. CNS dysfunction (which is often reversible) and narcosis have been frequently observed inhumans acutely exposed to low or moderate levels of toluene by inhalation; symptoms include fatigue,sleepiness, headaches, and nausea. CNS depression and death have occurred at higher levels of exposure. Toluene is used in veterinary medicine as a treatment for various parasites in dogs and cats. It is used for the removal of ascarids (Toxocara canis and Toxascaris leonina) and hookworms (Ancylostoma caninum and Uncinaria stenocephala) and as an aid in removing tapeworms (Taenia pisiformis, Dipylidium caninum, and Echinococcus granulosus) from dogs and cats.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The essential HupB and HupN proteins of Pseudomonas putida provide redundant and nonspecific DNA-bending functions. | 2001-05-18 |
|
| Solvent vapour monitoring in work space by solid phase micro extraction. | 2001-05-07 |
|
| Detection of catabolic genes in indigenous microbial consortia isolated from a diesel-contaminated soil. | 2001-05 |
|
| A stable organic free radical in anaerobic benzylsuccinate synthase of Azoarcus sp. strain T. | 2001-04-20 |
|
| Activity of different Candida antarctica lipase B formulations in organic solvents. | 2001-04-20 |
|
| Evaluation of natural attenuation rate at a gasoline spill site. | 2001-04-20 |
|
| Concise formation of 4-benzyl piperidines and related derivatives using a Suzuki protocol. | 2001-04-06 |
|
| Regio- and stereochemically controlled formation of hydroxamic acid containing anti- or syn-1,4-cycloalkenols from acylnitroso-derived Diels-Alder adducts. | 2001-04-06 |
|
| Suzuki reaction of vinyl triflates from six- and seven-membered N-alkoxycarbonyl lactams with boronic acids and esters. | 2001-04-06 |
|
| Enantioselective synthesis of (-)-wikstromol using a new approach via malic acid. | 2001-04-06 |
|
| A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. | 2001-04 |
|
| Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells. | 2001-04 |
|
| Differential distribution of sialic acid in alpha2,3 and alpha2,6 linkages in the apical membrane of cultured epithelial cells and tissues. | 2001-04 |
|
| Rapid reduction of intracellular glutathione in human bronchial epithelial cells exposed to occupational levels of toluene diisocyanate. | 2001-04 |
|
| Synthesis of biaryls via unusual deoxygenative dimerization of 1,4-epoxy-1,4-dihydroarenes catalyzed by palladium complexes. | 2001-03-22 |
|
| Design and evaluation of a breath-analysis system for biological monitoring of volatile compound. | 2001-03-22 |
|
| Dermal absorption of neat liquid solvents on brief exposures in volunteers. | 2001-03-22 |
|
| Peptide transport by the multidrug resistance protein MRP1. | 2001-03-15 |
|
| The determination of draining lymph node cell cytokine mRNA levels in BALB/c mice following dermal sodium lauryl sulfate, dinitrofluorobenzene, and toluene diisocyanate exposure. | 2001-03-15 |
|
| Significance of nucleobase shape complementarity and hydrogen bonding in the formation and stability of the closed polymerase-DNA complex. | 2001-03-13 |
|
| Determination of thiodyglycol in groundwater using solid-phase extraction followed by gas chromatography with mass spectrometric detection in the selected-ion mode. | 2001-03-09 |
|
| Stereocontrolled synthesis of acyclic 1,3-diols via condensation of tungsten-syn-pi-pentadienyl complexes with aldehydes. A new Prins reaction via s-trans-diene cationic intermediates. | 2001-03-09 |
|
| The role of delta-opioid receptor subtypes in neuropathic pain. | 2001-03-09 |
|
| Bioactive chemical constituents from Alchornea laxiflora (benth) pax and hoffman. | 2001-03-03 |
|
| C-Isoprenylation of flavonoids enhances binding affinity toward P-glycoprotein and modulation of cancer cell chemoresistance. | 2001-03-01 |
|
| Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis. | 2001-03-01 |
|
| Failure of GPI compounds to display neurotrophic activity in vitro and in vivo. | 2001-03 |
|
| 5-Benzyl-5-phenyl[1,3]dithiolo[4,5-d]-[1,3]dithiole-2-thione. | 2001-03 |
|
| 6,7-Bis(bromomethyl)-2,11,18,21,24-pentaoxatetracyclo. | 2001-03 |
|
| Molecular characterization of the cDNA encoding an acidic isoform of PR-1 protein in rice. | 2001-02-28 |
|
| Determination of monobromobimane derivatives of phenylmercapturic and benzylmercapturic acids in urine by high-performance liquid chromatography and fluorimetry. | 2001-02-25 |
|
| Indoor and outdoor BTX levels in German cities. | 2001-02-21 |
|
| Convenient synthesis of 4,6-di-O-benzyl-myo-inositol and myo-inositol 1,3,5-orthoesters. | 2001-02-15 |
|
| Selenoxides inhibit delta-aminolevulinic acid dehydratase. | 2001-02-03 |
|
| Titanium alkali metal nitrido complexes. | 2001-02-02 |
|
| Diverse profiles of specific IgE response to toluene diisocyanate (TDI)-human serum albumin conjugate in TDI-induced asthma patients. | 2001-02 |
|
| Formation of cleavage products by autoxidation of lycopene. | 2001-02 |
|
| Acetyl-coa: alcohol acetyltransferase activity and aroma formation in ripening melon fruits. | 2001-02 |
|
| Global and cognate regulators control the expression of the organic solvent efflux pumps TtgABC and TtgDEF of Pseudomonas putida. | 2001-02 |
|
| Health information in material safety data sheets for a chemical which causes asthma. | 2001-02 |
|
| A rapid method for peroxide value determination in edible oils based on flow analysis with Fourier transform infrared spectroscopic detection. | 2001-02 |
|
| Mixed dimer and mixed trimer complexes of nBuLi and a chiral lithium amide. | 2001-01-19 |
|
| The first crystalline alkali metal salt of a benzenoid radical anion without a stabilizing substituent and of a related dimer: X-ray structures of the toluene radical anion and of the benzene radical anion dimer potassium-crown ether salts. | 2001-01-10 |
|
| A capillary electrophoresis chip for the analysis of print and film photographic developing agents in commercial processing solutions using indirect fluorescence detection. | 2001-01 |
|
| Evaluation of porous ceramic as microbial carrier of biofilter to remove toluene vapor. | 2001-01 |
|
| Removal of toluene in gas streams by a fibrous-bed trickling filter. | 2001-01 |
|
| Application of high performance anion exchange chromatography to study invertase-catalysed hydrolysis of sucrose and formation of intermediate fructan products. | 2001-01 |
|
| BTEX catabolism interactions in a toluene-acclimatized biofilter. | 2001-01 |
|
| Efficient charge separation in porphyrin-fullerene-ligand complexes. | 2001 |
|
| Environment and medication use influence olfactory abilities of older adults. | 2001 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:33:08 GMT 2025
by
admin
on
Mon Mar 31 17:33:08 GMT 2025
|
| Record UNII |
3FPU23BG52
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C553
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
||
|
DEA NO. |
6594
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
||
|
CFR |
21 CFR 175.320
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
||
|
CFR |
21 CFR 520.580
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1311381
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | RxNorm | ||
|
m10958
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | Merck Index | ||
|
TOLUENE
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
17578
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
3FPU23BG52
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
DB11558
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
D014050
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
131
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
C77930
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
DTXSID7021360
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
406333
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
203-625-9
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
1140
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
100000124393
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
108-88-3
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
SUB32407
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
3FPU23BG52
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
1601805
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
UNSPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
Limit of Residual Solvents
CHROMATOGRAPHIC PURITY (GC)
USP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|